IASP Neuropathic Pain Special Interest Group (NeuPSIG) Data Blitz -- Group 2

Thank you

This live web event has ended. Thank you for attending.

Description

If you have registered for this webinar, please ensure you are logged in before proceeding to the live webinar. The log in appears in the top right corner. You will see your name displayed if you are already logged in.

PRF webinars are a complimentary IASP member benefit. If you are an IASP member, please log in using your IASP credentials, and register for this webinar for free.
If you are a nonmember and would like to access the webinar, the fee is USD $25. Please click “Add to Cart” to pay the fee and register. You will be asked to create a nonmember IASP account. If interested in joining IASP as a member, information on joining is included in the “Become an IASP Member” tab above. Questions about IASP membership can be directed to iaspdesk@iasp-pain.org.

The IASP Neuropathic Pain Special Interest Group (NeuPSIG) will host a data blitz virtual seminar featuring:

Amanda Klein, PhD, University of Minnesota, US
Decreased function of KATP Channels in the Peripheral and Central Nervous Systems in a Mouse Model of Diabetic Neuropathy

Makenzie Norris, PhD candidate, Washington University in St. Louis, US
Quantification of Limb Position in the Mouse Spared Nerve Injury Model Reveals Motor and Potentially Nocifensive Phenotypes

Mitchell Nothem, PhD, Drexel University, US
Primary Somatosensory and Anterior Cingulate Single-Unit Activity is Increased After Peripheral Nerve Injury and Altered by Gabapentin

A Q & A session moderated by Sulayman Dib-Hajj, PhD, Yale School of Medicine and VA Connecticut Healthcare System, will follow each presentation.

Contributors

Amanda Klein, PhD, University of Minnesota, US

Amanda H. Klein, PhD, received her BS in Cell Biology and a MS in Biology from the University of Minnesota Duluth. She received her PhD from the Molecular Cellular and Integrative Physiology program at the University of California Davis. During her graduate school career she has published manuscripts in the field of chemesthesis, looking at sensations of irritation in the oral cavity and skin by chemical mediators. During her postdoctoral training, Dr. Klein worked with Dr. Matthias Ringkamp in the Department of Neurosurgery and Dr. Srinivasa Raja of the Department of Anesthesiology and Critical Care Medicine, investigating the mechanisms of pain and itch using primary afferent recordings. The current focus of Dr. Klein's research revolves around the neural mechanisms of pain and opioid analgesia, and the role of downstream pathways, including potassium channels, to alleviate chronic pain, reduce tolerance, and decrease withdrawal symptoms.
Makenzie Norris, PhD candidate, Washington University in St. Louis, US

Makenzie Norris received her BS in neurobiology and physiology with minors in psychology and African-American studies from Purdue University. As a fourth-year neuroscience PhD student in the lab of Dr. Jordan McCall, she is interested in uncovering the interdependent mechanisms behind the intersection of stress and pain, and specifically how the locus coeruleus-norepinephrine (LC-NE) system modulates the process by which acute stress increases basal pain thresholds in mice. In addition, she has been working to develop an objective, high throughput pre-clinical pain assay using markerless pose estimation software with a goal to help facilitate more efficient pain therapeutic development in the future.
Mitchell Nothem, PhD, Drexel University, US

Mitch Nothem completed his PhD with Dr. James Barrett in 2020, where his dissertation focused on the effects of peripheral nerve injury and gabapentin on cortical pain processing as a strategy to find opioid alternatives for those in chronic pain. His postdoctoral work focuses on the interaction between chronic pain and substance use disorders. Mitch is also an avid member of the recovery community and is broadly interested in the development of treatments for chronic pain and substance use disorders.
Sulayman Dib-Hajj, PhD

Dr. Dib-Hajj is a Senior Research Scientist in the Yale School of Medicine and Graduate School, and Deputy Director of the Center for Restoration of Nervous System Function at the Veterans Administration Medical Center in West Haven, Connecticut. He received his undergraduate education from the American University of Beirut, Lebanon, and his PhD from the Ohio State University, Columbus, OH. His research for the past 2 decades at Yale and the VA has centered on the molecular basis of excitability disorders in humans including pain, with a focus on the role of voltage-gated sodium channels in the pathophysiology of these disorders, and as targets for new therapeutics. He has served on the Scientific Advisory Board of the Paralyzed Veterans of America Educational Foundation, and is currently serving on the Board of Directors of the National Disease Research Interchange. He serves on the editorial boards of several journals, and as a permanent member merit award panel at the VA BLRD service, and as ad hoc reviewer for the NIH and international funding organizations. He has published more than 200 primary papers and reviews, and has established national and international collaborations with academic and pharmaceutical groups.

DISCLOSURE: Nothing to disclose.